Mitoxantrone and condition aggravated Patient Reports February 10, 2010

Mitoxantrone Side Effects Report #5593249-6
Mitoxantrone side effect was reported by a Consumer or non-health professional from CHINA on Dec 27, 2007. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with prostate cancer  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, bronchitis , condition aggravated, escherichia infection, interstitial lung disease, lobar pneumonia, lung neoplasm, lymphadenopathy mediastinal. Mitoxantrone dosage: 20 MG Q3W IV. During the same period patient was treated with PREDNISONE, NEUPOGEN. Patient died on 10/26/2007.

Mitoxantrone Side Effects Report #5614887-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from CHINA on Jan 18, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with prostate cancer  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, bronchitis , condition aggravated, escherichia infection, feeling abnormal, interstitial lung disease, lung consolidation, lung infection, lymphadenopathy. Mitoxantrone dosage: 20 MG Q3W IV. During the same period patient was treated with PREDNISONE, NEUPOGEN. Patient died on 10/26/2007.

Mitoxantrone Side Effects Report #5081951-4
Mitoxantrone side effect was reported by a Physician from GERMANY on July 31, 2006. Male patient, 40 years of age, was diagnosed with progressive multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: condition aggravated, psoriasis. Mitoxantrone dosage: unknown. Patient recovered.

Mitoxantrone Side Effects Report #5096493-X
Mitoxantrone side effect was reported by a Health Professional from GERMANY on Aug 17, 2006. Male patient, 61 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, cerebral haemorrhage, condition aggravated, retinal haemorrhage. Mitoxantrone dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Mitoxantrone Side Effects Report #4819843-5
Mitoxantrone side effect was reported by a Consumer or non-health professional from GERMANY on Oct 19, 2005. Female patient, 52 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: autoimmune hepatitis, condition aggravated, hepatic encephalopathy. Mitoxantrone dosage: 14 MG, ONCE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #5905868-5
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on Oct 01, 2008. Male patient, 41 years of age, weighting 195.0 lb, was diagnosed with demyelination and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, borrelia infection, central nervous system lesion, condition aggravated, demyelination. Mitoxantrone dosage: unknown. During the same period patient was treated with ZOFRAN, IV SOLUMEDROL. Patient recovered.

Mitoxantrone Side Effects Report #5369645-9
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on June 14, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: central line infection, condition aggravated, febrile neutropenia, hypotension, oxygen saturation decreased, pleural effusion, pneumonia . Mitoxantrone dosage: 16.7 MG QD IV. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.